Core Insights - Tencent Healthcare has launched the Next Generation Engagement Suite R4.0 (NGES R4.0) to assist global pharmaceutical multinationals in leveraging AI technology for operations and market expansion in China [1][8] - The upgrade integrates AI technology into pharmaceutical digital marketing, enhancing customer engagement and resource management [4][5] AI Technology Integration - NGES R4.0 enhances efficiency, management, and compliance in pharmaceutical scenarios such as multi-channel marketing and Customer Relationship Management (CRM) [2][4] - The dual-model capability of NGES R4.0 allows seamless switching between Tencent Hunyuan and DeepSeek models, improving content production efficiency and compliance [5][6] Annotation and Content Generation - The system presets over 10 professional labels, increasing annotation accuracy by 60% compared to traditional models through innovative integration of medical knowledge and semantic understanding [6][7] - NGES R4.0 supports the generation of professional academic content, including academic abstracts and intelligent title optimization, while ensuring compliance with medical terminology [5][6] Broader Industry Impact - Tencent Healthcare's solutions extend beyond NGES R4.0, offering AI applications for clinical trials, drug research, and medical translation, thus supporting the pharmaceutical industry's digital transformation [7][8] - The introduction of distributed cloud and AI knowledge engines enables rapid deployment and optimization of AI applications for enterprises [7]